Example: Heart Attack

Search clinical trials for: Alogliptin

Total 58 results

NCT03794336

Completed

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Conditions: Type 2 Diabetes Mellitus
NCT03555565

Completed

Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"

Conditions: Type 2 Diabetes Mellitus
NCT02856113

Recruiting

Phase 3 Alogliptin Pediatric Study

Conditions: Diabetes Mellitus, Type 2
NCT04470310

Active, not recruiting

Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination

Conditions: Type 2 Diabetes Mellitus
NCT03950505

Recruiting

To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes

Conditions: Non-alcoholic Steatohepatitis, Type2 Diabetes
NCT04392557

Recruiting

Anti-inflammatory Status in DM2 Treated Patients

Conditions: Diabetes Mellitus, Type 2
NCT03499704

Recruiting

A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy

Conditions: Diabetes Mellitus, Type 2
NCT01964963

Completed

Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT01945216

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"

Conditions: Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
NCT02221284

Completed

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

Conditions: Type 2 Diabetes Mellitus
NCT03501277

Completed

A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants

Conditions: Healthy Volunteers
NCT02756832

Completed

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Conditions: Diabetes Mellitus
NCT02763007

Terminated

An Extension Study of PEAK Trial

Conditions: Diabetes Mellitus, Type 2
NCT03231709

Completed

Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT02989649

Terminated

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Conditions: Diabetes Mellitus, Type 2
NCT02231021

Completed

The Practical Evidence of Antidiabetic Combination Therapy in Korea

Conditions: Type 2 Diabetes Mellitus
NCT01990300

Completed

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT02771093

Completed

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT03042325

Withdrawn

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT01664624

Completed

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Conditions: Type 2 Diabetes
NCT01890122

Completed

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

Conditions: Diabetes Mellitus
NCT02508168

Completed

Phase 1 Bioavailability Study of SYR-322MET

Conditions: Healthy Volunteers
NCT01945242

Completed

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

Conditions: Type 2 Diabetes Melitus
NCT02798172

Completed

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Conditions: Diabetes Mellitus, Type 2
NCT02068443

Completed

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Conditions: Type 2 Diabetes Mellitus